Aigen Investment Management LP Acquires 276 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Aigen Investment Management LP raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 27.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,277 shares of the biotechnology company’s stock after purchasing an additional 276 shares during the period. Aigen Investment Management LP’s holdings in Axon Enterprise were worth $510,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. Ashton Thomas Private Wealth LLC increased its holdings in shares of Axon Enterprise by 2.9% during the third quarter. Ashton Thomas Private Wealth LLC now owns 1,883 shares of the biotechnology company’s stock valued at $752,000 after acquiring an additional 53 shares in the last quarter. Verus Capital Partners LLC bought a new stake in Axon Enterprise during the 3rd quarter valued at about $260,000. Sumitomo Mitsui Trust Group Inc. raised its holdings in Axon Enterprise by 2.5% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 159,322 shares of the biotechnology company’s stock worth $63,665,000 after buying an additional 3,924 shares during the last quarter. Patron Partners LLC bought a new position in shares of Axon Enterprise in the third quarter worth approximately $209,000. Finally, GSA Capital Partners LLP grew its holdings in shares of Axon Enterprise by 61.2% during the third quarter. GSA Capital Partners LLP now owns 1,736 shares of the biotechnology company’s stock valued at $694,000 after buying an additional 659 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Up 0.5 %

NASDAQ AXON opened at $604.56 on Friday. Axon Enterprise, Inc. has a 52 week low of $220.77 and a 52 week high of $624.84. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $46.10 billion, a P/E ratio of 156.22, a price-to-earnings-growth ratio of 14.95 and a beta of 0.94. The stock’s 50-day moving average price is $433.89 and its 200-day moving average price is $355.28.

Analysts Set New Price Targets

AXON has been the topic of several analyst reports. The Goldman Sachs Group upped their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Needham & Company LLC increased their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Barclays boosted their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Robert W. Baird raised their price target on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $427.83.

Insiders Place Their Bets

In other Axon Enterprise news, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the sale, the chief financial officer now directly owns 98,825 shares of the company’s stock, valued at $37,449,733.75. This trade represents a 4.20 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the sale, the president now owns 208,166 shares in the company, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 411,006 shares of company stock worth $161,360,618. Corporate insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.